Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOPHIE: Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia
NCT06327373Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of oxygen in pulmonary hypertension (PH), hypoxemia, sponsored by Duke University. Planned start Jul 2026; status: withdrawn.
02
Drugs
oxygen
03
Conditions
pulmonary hypertension (PH)hypoxemia
Beyond the preview
Go deeper on NCT06327373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06327373.